rs3752651

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_005228.5(EGFR):​c.1631+219T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.151 in 152,250 control chromosomes in the GnomAD database, including 1,980 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.15 ( 1980 hom., cov: 33)

Consequence

EGFR
NM_005228.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.261

Publications

25 publications found
Variant links:
Genes affected
EGFR (HGNC:3236): (epidermal growth factor receptor) The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor, thus inducing receptor dimerization and tyrosine autophosphorylation leading to cell proliferation. Mutations in this gene are associated with lung cancer. EGFR is a component of the cytokine storm which contributes to a severe form of Coronavirus Disease 2019 (COVID-19) resulting from infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). [provided by RefSeq, Jul 2020]
EGFR Gene-Disease associations (from GenCC):
  • lung cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P, Ambry Genetics
  • non-small cell lung carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • inflammatory skin and bowel disease, neonatal, 2
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • neonatal inflammatory skin and bowel disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 7-55161850-T-C is Benign according to our data. Variant chr7-55161850-T-C is described in ClinVar as Benign. ClinVar VariationId is 1225850.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.197 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005228.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EGFR
NM_005228.5
MANE Select
c.1631+219T>C
intron
N/ANP_005219.2
EGFR
NM_001346899.2
c.1496+219T>C
intron
N/ANP_001333828.1
EGFR
NM_001346900.2
c.1472+219T>C
intron
N/ANP_001333829.1C9JYS6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EGFR
ENST00000275493.7
TSL:1 MANE Select
c.1631+219T>C
intron
N/AENSP00000275493.2P00533-1
EGFR
ENST00000455089.5
TSL:1
c.1496+219T>C
intron
N/AENSP00000415559.1Q504U8
EGFR
ENST00000344576.7
TSL:1
c.1631+219T>C
intron
N/AENSP00000345973.2P00533-3

Frequencies

GnomAD3 genomes
AF:
0.151
AC:
23047
AN:
152132
Hom.:
1982
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0738
Gnomad AMI
AF:
0.275
Gnomad AMR
AF:
0.176
Gnomad ASJ
AF:
0.170
Gnomad EAS
AF:
0.115
Gnomad SAS
AF:
0.116
Gnomad FIN
AF:
0.121
Gnomad MID
AF:
0.222
Gnomad NFE
AF:
0.200
Gnomad OTH
AF:
0.180
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.151
AC:
23036
AN:
152250
Hom.:
1980
Cov.:
33
AF XY:
0.147
AC XY:
10949
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.0738
AC:
3065
AN:
41550
American (AMR)
AF:
0.175
AC:
2686
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.170
AC:
588
AN:
3468
East Asian (EAS)
AF:
0.114
AC:
593
AN:
5188
South Asian (SAS)
AF:
0.116
AC:
561
AN:
4822
European-Finnish (FIN)
AF:
0.121
AC:
1279
AN:
10608
Middle Eastern (MID)
AF:
0.218
AC:
64
AN:
294
European-Non Finnish (NFE)
AF:
0.200
AC:
13576
AN:
67994
Other (OTH)
AF:
0.177
AC:
374
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1014
2028
3041
4055
5069
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
252
504
756
1008
1260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.186
Hom.:
8470
Bravo
AF:
0.154
Asia WGS
AF:
0.122
AC:
427
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
4.3
DANN
Benign
0.70
PhyloP100
0.26
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3752651; hg19: chr7-55229543; COSMIC: COSV51773959; API